Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Shaw Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Battling Blood-Sucking Bugs
      • Unexpected Leads to Curb Addiction
      • Shaping Therapies for Sickle Cell Disease
      • The Mind’s Map Maker
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
I am Intramural Blog

Study Explores Sex Differences in Flu

Differences in Flu-Fighting Antibodies Could Explain Women’s Greater Susceptibility

By Brandon Levy

Tuesday, September 28, 2021

sick woman and man

New IRP research points to a possible biological reason why the flu tends to be more serious in women than men.

It is well-known that COVID-19 infections are more often life-threatening in the elderly and individuals with chronic medical conditions like obesity, but the novel coronavirus isn’t the only infectious disease that more severely affects certain groups of people. A new IRP study explored a possible biological reason why women tend to experience worse flu infections and suggests a way to potentially improve the effectiveness of flu vaccines for everyone.1

Whenever a large flu outbreak occurs, like the 1918 Spanish flu pandemic or the global spread of ‘swine flu’ in 2009, scientists sift through the data to see how people of different ages, ethnicities, and genders were affected. Many of these studies have shown that the flu affects women more strongly than men. What’s more, the immune responses of men and women to flu vaccines can also differ wildly, with one study showing that a half-dose of a flu vaccine caused women to produce just as many flu-fighting antibodies as men did when given a full dose of the same vaccine.2

“We don’t understand a lot of things about the course of these respiratory virus infections,” says Luca Giurgea, M.D., an IRP clinical fellow who studies the flu in the lab of IRP senior investigator Matthew Memoli, M.D., M.S. “When some people do fine and some get really sick, it’s not clear what’s different about those people, let alone what makes someone not get sick at all. We don’t understand all the factors that are at play, and I think this male-female dichotomy is a very high-yield thing to go after to explore what’s really driving these differences that have very real ramifications for disease management.”

More From the IRP
Blog
Mold Exposure Sets Stage for Severe Flu

However, ‘retrospective’ studies that look back at past outbreaks to learn about the flu’s differing effects in men and women are complicated by many non-biological factors. For example, in many cultures, women tend to spend more time with children than men do, resulting in greater exposure to the respiratory viruses that are common among children. Researchers attempt to overcome these issues with ‘human challenge studies,’ in which participants are exposed to identical doses of a virus and their experiences are examined in a standardized manner.

The new IRP study, led by Dr. Giurgea and Dr. Memoli, combined data from four human challenge studies that Dr. Memoli’s lab had previously conducted. Consistent with prior research, they found that the men in the studies experienced slightly fewer flu symptoms on average compared to the women after they were exposed to the virus. Men were also 16 percent less likely than women to have any symptoms at all.

Image credit: CDC/Dan Higgins

Illustration of a whole influenza virus with a light grey surface membrane and the virus’ surface proteins hemagluttinin (light blue) and neuraminidase (dark blue).

The researchers also examined the levels of two flu-fighting antibodies in the participants’ blood before and after exposure to the virus. One of these antibodies inhibits a flu protein, called hemagglutinin, that the virus uses to gain entry into cells. The other inhibits a flu protein called neuraminidase, which helps the virus extract itself from a cell it has infected so it can proceed to infect another cell.

“When you hear the names of different flu strains, like H1N1 or H3N2, that refers to the type of hemagglutinin — the H — and the type of neuraminidase — the N — that it has,” Dr. Giurgea explains.

Unsurprisingly, levels of antibodies against hemagglutinin and neuraminidase increased after flu exposure in both men and women. However, whereas levels of antibodies against hemagglutinin were similar in men and women four and eight weeks after exposure, men had much higher levels of antibodies against neuraminidase at those time points. Moreover, the more neuraminidase antibodies a person had at baseline prior to flu exposure, the less severe his or her illness was afterwards, including having fewer symptoms, having symptoms for a shorter period of time, being more likely to be completely asymptomatic, and being less likely to have detectable levels of the virus in the nose. Pre-exposure levels of neuraminidase antibodies were lower on average in women than men, but the difference did not quite reach statistical significance.

person receiving a flu shot

Standardizing, and maybe increasing, the amount of flu neuraminidase protein in vaccines could potentially boost their effectiveness.

Overall, the new study suggests that differences in the levels of neuraminidase-inhibiting antibodies may partly explain why women tend to experience worse flu infections than men. The results also bolster the argument, long championed by Dr. Memoli’s lab, that scientists and vaccine developers should pay more attention to the importance of antibodies against neuraminidase. Right now, flu vaccines contain a standard amount of the flu hemagglutinin protein, but the amount of neuraminidase in them can vary widely. Addressing this imbalance could make seasonal flu vaccines better at preventing illness.

“Flu vaccines have had underwhelming effectiveness sometimes,” Dr. Giurgea says. “The flu is a rapidly mutating virus, and I think adding the neuraminidase could particularly help against the mutation problem because we’d be hitting two targets — now the virus would have to mutate both its hemagglutinin and neuraminidase in order to evade the vaccine. I think creating vaccines that elicit this multi-faceted immune response against multiple targets might help alleviate those types of problems.”

Subscribe to our weekly newsletter to stay up-to-date on the latest breakthroughs in the NIH Intramural Research Program.

References:

[1] Sex Differences in Influenza: The Challenge Study Experience. Giurgea LT, Cervantes-Medina A, Walters K, Scherler K, Han A, Czaikowski LM, Baus HA, Hunsberger S, Klein SL, Kash JC, Taubenberger JK, Memoli MJ. J Infect Dis. 2021 Aug 23;jiab422. doi: 10.1093/infdis/jiab422.

[2] Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Engler RJM, Nelson MR, Klote MM, VanRaden MJ, Huang C, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, Treanor JJ, Walter Reed Health Care System Influenza Vaccine Consortium. Arch Intern Med. 2008 Dec 8; 168(22):2405-14. doi: 10.1001/archinternmed.2008.513.


Category: IRP Discoveries
Tags: Test Tube Tuesday, virus, flu, influenza, virology, gender, vaccines

Related Blog Posts

  • A New Approach to Fighting the Flu
  • An Ebola Therapy Two Decades in the Making
  • IRP’s Anthony Fauci Talks COVID-19 With Stephen Curry
  • Leading the Charge Against Infectious Disease
  • A Record-Breaking Sprint to Create a COVID-19 Vaccine

This page was last updated on Tuesday, May 23, 2023

Blog menu

  • Contributing Authors
    • Anindita Ray
    • Brandon Levy
    • Devon Valera
    • Melissa Glim
  • Categories
    • IRP Discoveries
    • Profiles
    • Events
    • NIH History
    • IRP Life

Blog links

  • Subscribe to RSS feed

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search